Tamoxifen effects on endometrium

Panminerva Medica

Volumn 42, Issue 1, 2000, Pages 45-47

  Colacurci, N ^a,b   De Seta, L ^a   De Franciscis, P ^a   Mele, D ^a   Fortunato, N ^a   Cassese, S ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b NONE   (Italy)

Author keywords

Breast neoplasms; Endometrium, ultrasonography; Hysteroscopy; Tamoxifen adverse effects

Indexed keywords

ANTIESTROGEN; TAMOXIFEN;

AGED; ARTICLE; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ENDOMETRIUM; ENDOMETRIUM TUMOR; FEMALE; HUMAN; MIDDLE AGED; POSTOPERATIVE COMPLICATION;

AGED; BREAST NEOPLASMS; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; TAMOXIFEN;

EID: 0034149422     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Early Breast Cancer Trialists' Cooperative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy: 133 randomised trials involving 31000 recurrences and 24000 deaths among 75000 women. Lancet 1992;339(1-15):71-85.
2. Nayfield SG, Karp JE, Ford LG, Dorr FA, Kramer BS. Potential role of Tamoxifen in prevention of breast cancer. J Natl Cancer Inst 1991;83(20):1450-9.
3. Willen R, Lindahl B, Andolf E, Ingvar C, Liedam R, Ranstam J. Histopathologic findings in thickened endometria, as measured by ultrasound in asymptomatic, postmenopausal breast cancer patients on various adjuvant. Anticancer Res 1998;18(1B):667-76.
4. Andersson M, Storm HH, Mouridsen HT. Incidence of new primary cancers after adjuvant Tamoxifen therapy and radiotherapy for early breast cancer. J Natl Cancer Inst 1991;83:1013-7.
5. Stearns V, Gelman Ep. Does Tamoxifen cause cancer in humans. J Clin Oncol 1998;16(2):779-92.
6. Berliere M, Charles A, Galant C, Donnez J. Uterine side effects of Tamoxifen: a need for systematic pretreatment screening. Obstet Gynecol 1998;91(1):40-4.
7. Konstostolis E, Stefanidis K, Navrozoglou I, Mouzakioti E, Paschopoulos M, Lolis D. The effects of Tamoxifen on the endometrium, blood flow of the uterine arteries and serum lipoprotein(a) levels in postmenopausal women. Gynecol Endocrinol 1998;12(3):185-9.
8. Fisher B. Commentary on endometrial cancer deaths in Tamoxifen-treated breast cancer patients. J Clin Oncol 1990:14(3):1027-39.
9. Katase K, Sugiyama Y, Hasumi K, Yoshimoto M, Kasumi F. The incidence of subsequent endometrial carcinoma with Tamoxifen use in patients with primary breast carcinoma. Cancer 1998;82(9):1698-703.
10. Davidson NE. Tamoxifen-Panacea or Pandora's box? N Engl J Med 1992;326(13):885-6.
11. Cohen I, Rosen DJD, Saphira J, Cordoba M, Gilboa S, Altaras MM et al. Endometrial changes in postmenopausal women treated with Tamoxifen for breast cancer. Br J Obstet Gynecol 1993;100: 567-70.
12. Daniel Y, Inbar M, Bar-Am A, Peyser ML, Lessing JB. The defects of Tamoxifen treatment on the endometrium. Fertil Steril 1996;65(6):1083-7.
13. Cohen I, Rosen DJD, Saphira J, Cordoba M, Gilboa S, Altaras MM et al. Endometrial changes with Tamoxifen: comparison between Tamoxifen-treated and nontreated asymptomatic, postmenopausal breast cancer patients. Gynecol Oncol 1994;52:185-90.
14. Magriples U, Naftolin F, Schwartz PE, Carcangiu ML. High-grade endometrial carcinoma in Tamoxifen-treated breast cancer patients. J Clin Oncol 1993;11:485-90.
15. Fisher B. Commentary on endometrial cancer deaths in Tamoxifen-treated breast cancer patients. J Clin Oncol 1993;11:485-90.
16. Boccardo F, Guarneri D, Rubagotti A, Casertelli GL, Bentivoglio G, Conte N et al. Endocrine effects of Tamoxifen in postmenopausal breast cancer patients. Tumori 1984;70(1):61-8.
17. Nephew KP, Polek TC, Khan SA. Tamoxifen-induced proto-oncogene expression persists in uterine endometrial epithelium. Endocrinology 1996;137(1):219-24.
18. Niwa K, Morishita S, Hashimoto M, Itoh T, Fugjimoto J, Mori H et al. Effects of Tamoxifen on endometrial carcinogenesis in mice. Jpn J Cancer Res 1998;89(5):502-9.
19. Ismail SM. Pathology of endometrium treated with Tamoxifen. J Clin Pathol 1994;47:827-33.
20. McGonigle KF, Shaw SL, Vasilev SA, Odom-Maryon T, Rot S, Simpson JF. Abnormalities detected on transvaginal ultrasonography in Tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy. Am J Obstet Gynecol 1998:178(6):1145-50.